Dianthus Therapeutics, Inc. · 3 months ago
Director / Senior Director, Clinical Development Scientist
Dianthus Therapeutics, Inc. is developing innovative therapies for severe autoimmune diseases. The Senior Director, Clinical Development Scientist will lead scientific aspects of global Phase III trials, providing leadership in protocol development and regulatory strategy to drive the progress of a novel therapeutic asset.
BiopharmaBiotechnologyHealth Care
Responsibilities
Serve as scientific lead on assigned Phase III/late-stage trial(s): define protocol and endpoints, author or review regulatory‐relevant documents, ensure protocol integrity and compliance
Collaborate cross-functionally (clinical operations, biostatistics, regulatory, safety) to support feasibility, site selection, study start-up, and execution across regions
Oversee safety and efficacy data monitoring: identify trends, support medical monitoring, work with DSMBs/DMCs, ensure timely reporting and regulatory compliance
Support and contribute to the development and refinement of the overall Clinical Development Plan and associated evidence generation strategy
Maintain and apply knowledge of disease biology, competitive landscape, therapeutic modalities, and regulatory/scientific advancements relevant to the therapeutic area
Facilitate external relationships: sites, investigators, KOLs, CROs, regulatory agencies
Provide mentorship, guidance, and scientific oversight to team members on scientific content and trial execution
Produce and support publications, presentations, and internal/external communications of trial findings and strategic insights
Ability to travel 15-20%
Qualification
Required
Advanced degree in life/health sciences (PhD, PharmD, MD, MPH or equivalent)
Deep understanding of rare disease, neurology, immunology, or a closely related field
Extensive knowledge of drug development processes (late-phase trials), GCP/ICH standards, clinical operations, study design, safety monitoring, and statistics
Demonstrated experience drafting and reviewing protocols, regulatory documents, medical monitoring plans, safety reports, etc
Excellent scientific writing ability and meticulous attention to detail
Strong skills in data review, trend identification, data interpretation, and safety oversight, including experience with DSMBs/DMCs or other safety governance
Effective communication, both written and verbal, with ability to engage with internal teams, investigators, CROs, regulatory bodies, and external experts
Strategic mindset with ability to balance long-term goals and tactical needs
Experience working across geographies and multimodal teams; capable of influencing without direct authority
Proficiency in tools commonly used in clinical development (e.g. Microsoft Office, EDC systems, data platforms)
Company
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$639.5M2025-09-09Post Ipo Equity· $288M
2024-01-22Post Ipo Equity· $230M
2023-09-12IPO
Leadership Team
Recent News
Clinical Trials Arena
2025-12-25
Company data provided by crunchbase